Stay updated on Bempegaldesleukin Combo in Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the Bempegaldesleukin Combo in Urothelial Cancer Clinical Trial page.

Latest updates to the Bempegaldesleukin Combo in Urothelial Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe study page now shows a 403 Forbidden error instead of the trial details, with added HTML indicating a 403 state. This means the NCT03785925 record is currently inaccessible on ClinicalTrials.gov.SummaryDifference18%

- Check39 days agoChange DetectedAdded NIH grant/contract attribution for 2018 and updated the site revision to v3.6.6, replacing the previous v3.6.5.SummaryDifference0.1%

- Check61 days agoChange DetectedThe page now shows Revision: v3.6.5, replacing the previous v3.6.4. This is a metadata/version update and does not alter the displayed study information.SummaryDifference0.0%

- Check75 days agoChange DetectedThe page's revision tag was updated from v3.6.3 to v3.6.4, signaling a small update to the page's content or metadata.SummaryDifference0.0%

- Check96 days agoChange DetectedThe page footer now shows Revision: v3.6.3, replacing v3.6.2, indicating a minor update to the page rendering.SummaryDifference0.0%

- Check103 days agoChange DetectedThe page updated its revision label to v3.6.2, replacing the previous v3.6.0. This appears to be a small maintenance update that does not change the study details or how the information is presented.SummaryDifference0.0%

Stay in the know with updates to Bempegaldesleukin Combo in Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bempegaldesleukin Combo in Urothelial Cancer Clinical Trial page.